세계의 헬스케어 분야 불소수지 시장 보고서(2025년)
Fluoropolymer In Healthcare Global Market Report 2025
상품코드 : 1764320
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

헬스케어 분야 불소수지 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 시장 성장은 인프라에 대한 투자 증가, 감염 제어에 대한 의식 고조, 내열 재료에 대한 요구의 확대 등에 기인하고 있습니다.

최소 침습 수술 기구 수요가 증가함에 따라 헬스케어 시장에서 불소수지의 성장을 이끌 것으로 예측됩니다. 최소 침습 수술 기구는 작은 절개를 통해 수술을 수행하는 데 사용되는 첨단 도구입니다. 회복 시간 단축 등의 장점 또한 수요 증가에 박차를 가하고 있습니다. 불소수지는 내약품성, 저마찰성, 생체 적합성의 특성으로 이러한 도구에 필요하며 기구의 성능을 높이고 환자의 안전을 확보하고 있습니다. Intuitive Surgical, Inc.는 2024년에 동사의 수술 제품이 270만 건 가까이의 수술에 사용되었으며 2023년에 비해 17% 증가했다고 보고했습니다.

헬스케어 분야 불소수지 시장의 주요 기업은 의료 기기나 진단 용도의 정밀도와 내구성을 향상시키기 위해 불소수지 베이스의 유체 시스템 등의 선진 제품 개발에 주력하고 있습니다. 이러한 시스템은 연구소 환경에서 유체의 흐름을 정확하고 안전하게 관리합니다. Biotech Fluidics AB는 2023년 5월 트레이서블로 인증된 PEEK 및 불소수지제 플렉서블 튜브의 새로운 라인을 발표했습니다. 새로운 튜브는 ISO 10993, 미국 약전 클래스 VI, FDA 타이틀 21, EU 규칙 1907/2006(DEHP 함량에 관함)과 같은 엄격한 표준을 준수합니다. 이 튜브는 필요에 따라 클린룸 내에서 멸균된 상태로 납품할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 팬데믹과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Fluoropolymers are high-performance materials extensively used in healthcare due to their outstanding chemical resistance, biocompatibility, and ability to endure high temperatures. Their non-reactive and non-stick nature makes them highly suitable for medical devices, offering consistent performance and durability, even after repeated sterilization. Their inertness and strength also make them well-suited for fluid handling applications.

The primary types of fluoropolymers used in healthcare include polytetrafluoroethylene (PTFE), polyvinylidene difluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polyvinyl fluoride (PVF), and others. PTFE is a heat-resistant, low-friction, and chemically inert fluoropolymer valued in medical applications for its strength and biocompatibility. It is available in multiple forms such as films, coatings, wrappings, and tubings-and serves a range of uses including medical devices, pharmaceutical packaging, laboratory instruments, and protective apparel. These materials are utilized by end-users like hospitals and clinics, pharmaceutical companies, research laboratories, and contract manufacturing organizations (CMOs).

The fluoropolymer in healthcare market research report is one of a series of new reports from The Business Research Company that provides fluoropolymer in healthcare market statistics, including the fluoropolymer in healthcare industry global market size, regional shares, competitors with the fluoropolymer in healthcare market share, detailed fluoropolymer in healthcare market segments, market trends, opportunities, and any further data you may need to thrive in the fluoropolymer in healthcare industry. This fluoropolymer in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fluoropolymers in the healthcare market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to the increased adoption of medical catheters, a rise in the use of minimally invasive surgical procedures, growing demand for biocompatible materials, greater preference for disposable medical equipment, and the rising prevalence of chronic diseases.

The fluoropolymers in the healthcare market size is expected to see strong growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth anticipated in the forecast period can be attributed to the rising demand for advanced drug delivery systems, increased use of fluoropolymer coatings in surgical instruments, growing investments in healthcare infrastructure, heightened awareness of infection control, and the expanding need for temperature-resistant materials. Key trends expected during this period include innovations in medical tubing design, advancements in biocompatible fluoropolymers, progress in additive manufacturing technologies, research into sustainable fluoropolymer materials, and the integration of smart fluoropolymer-based devices.

The rising demand for minimally invasive surgical devices is expected to drive the growth of fluoropolymers in the healthcare market. Minimally invasive surgical devices (MISDs) are advanced tools used to perform procedures through small incisions, aiming to reduce recovery time and minimize complications. This growing demand is fueled by the need for faster recovery, as MISDs cause less bodily trauma and lead to shorter hospital stays. Fluoropolymers play a crucial role in these devices due to their chemical resistance, low friction, and biocompatibility, which enhance device performance and ensure patient safety. Their durability enables precise and dependable surgical operations. For example, in January 2025, Intuitive Surgical, Inc., a U.S.-based medical device company, reported that its surgical products were used in nearly 2.7 million procedures in 2024, representing a 17% increase compared to 2023. Thus, the growing demand for minimally invasive surgical devices is contributing to the expansion of fluoropolymers in the healthcare market.

Leading companies in the fluoropolymers healthcare market are focusing on the development of advanced products, such as fluoropolymer-based fluidic systems, to improve precision and durability in medical devices and diagnostic applications. These systems utilize fluoropolymer materials to manage fluid flow accurately and safely in medical and laboratory environments. Their chemical resistance, low friction, and biocompatibility ensure reliable performance in critical healthcare uses. For example, in May 2023, Biotech Fluidics AB, a Sweden-based provider of fluidic and degassing solutions, introduced a new line of traceable, certified PEEK and fluoropolymer flexible tubing. This tubing is designed for use in regulated environments such as medical and life sciences and complies with stringent standards, including ISO 10993, US Pharmacopeia Class VI, FDA Title 21, and EU Regulation 1907/2006 (regarding DEHP content). Available in both bulk and pre-cut quantities with complete traceability, the tubing can also be delivered sterilized in cleanroom assemblies when required. It is engineered to meet rigorous international regulatory requirements, making it well-suited for critical applications where safety, biocompatibility, and traceability are essential.

In February 2024, EQT Private Equity, a Sweden-based investment firm, acquired Zeus for an undisclosed amount. Through this acquisition, EQT Private Equity intends to support Zeus's expansion and innovation in advanced polymer solutions, with a focus on the medical and high-tech sectors. Zeus is a U.S.-based company specializing in the design, development, and extrusion of fluoropolymer tubing used in medical devices.

Major players in the fluoropolymer in healthcare market are Saint-Gobain S.A., Daikin Industries Ltd., 3M Company, Solvay S.A., AGC Inc., DuPont de Nemours Inc., Arkema S.A., Orbia, The Chemours Company, Datwyler, Kureha Corporation, Pexco, Gujarat Fluorochemicals Ltd., Specialty Coating Systems Inc., W.L. Gore & Associates, Duke Empirical, Halopolymer OJSC, Fluorotherm, Dalau Limited, Everflon Fluoropolymers.

North America was the largest region in the fluoropolymers in the healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fluoropolymers in the healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fluoropolymers in the healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fluoropolymers in the healthcare market consist of sales of perfluoropolyether, perfluorocyclobutyl polymers, and fluoroethylene propylene rubber. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fluoropolymer In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fluoropolymer in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for fluoropolymer in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fluoropolymer in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Fluoropolymer In Healthcare Market Characteristics

3. Fluoropolymer In Healthcare Market Trends And Strategies

4. Fluoropolymer In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Fluoropolymer In Healthcare Growth Analysis And Strategic Analysis Framework

6. Fluoropolymer In Healthcare Market Segmentation

7. Fluoropolymer In Healthcare Market Regional And Country Analysis

8. Asia-Pacific Fluoropolymer In Healthcare Market

9. China Fluoropolymer In Healthcare Market

10. India Fluoropolymer In Healthcare Market

11. Japan Fluoropolymer In Healthcare Market

12. Australia Fluoropolymer In Healthcare Market

13. Indonesia Fluoropolymer In Healthcare Market

14. South Korea Fluoropolymer In Healthcare Market

15. Western Europe Fluoropolymer In Healthcare Market

16. UK Fluoropolymer In Healthcare Market

17. Germany Fluoropolymer In Healthcare Market

18. France Fluoropolymer In Healthcare Market

19. Italy Fluoropolymer In Healthcare Market

20. Spain Fluoropolymer In Healthcare Market

21. Eastern Europe Fluoropolymer In Healthcare Market

22. Russia Fluoropolymer In Healthcare Market

23. North America Fluoropolymer In Healthcare Market

24. USA Fluoropolymer In Healthcare Market

25. Canada Fluoropolymer In Healthcare Market

26. South America Fluoropolymer In Healthcare Market

27. Brazil Fluoropolymer In Healthcare Market

28. Middle East Fluoropolymer In Healthcare Market

29. Africa Fluoropolymer In Healthcare Market

30. Fluoropolymer In Healthcare Market Competitive Landscape And Company Profiles

31. Fluoropolymer In Healthcare Market Other Major And Innovative Companies

32. Global Fluoropolymer In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fluoropolymer In Healthcare Market

34. Recent Developments In The Fluoropolymer In Healthcare Market

35. Fluoropolymer In Healthcare Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기